Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-24

Clinical Trial Update: Nigella Sativa Supplementation in Hyperlipidemia Treatment [NA]

View source ↗

Summary

A completed clinical trial evaluated Nigella Sativa supplementation for hyperlipidemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nigella Sativa supplement (Nigella sativa)

Snippet

Sponsor: Istanbul Bilgi University | Conditions: Hyperlipidaemia, Hyperlipidemia | NA | Status: COMPLETED